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The Southern HIV/AIDS Strategy Initiative (SASI) applauds CDC’s high-impact HIV 
prevention approach that apportions funding to states, territories and directly funded 
cities based on the number of people reported to be living with HIV in the jurisdiction 
rather than on cumulative AIDS cases. SASI also supports funding for the ten cities that 
account for approximately 37 percent of people living with HIV in the United States and for 
the 36 jurisdictions with at least 3,000 African American and Hispanic residents living with 
an HIV diagnosis to support HIV testing for populations disproportionately affected by 
HIV.1   
 
CDC’s recent decision to restrict eligibility for prevention funding for community 
based organizations (CBOs) to those located in designated metropolitan statistical areas 
(MSAs), however, removes crucial funding for a region that has experienced 
disproportionately high HIV diagnosis and death rates.2 CDC’s recent funding 
announcement, PS15-1502, was designed to maximize funding effectiveness by “reach[ing] 
those areas with the greatest need for HIV prevention services targeting the selected 
population.”3 When the data is examined on a state level, several Deep South States have a 
significantly higher percentage of their HIV burden in non-urban areas, as shown by the 
diagram below. Overwhelmingly, these are areas that are ineligible for direct CBO funding 
under PS15-1502. In essence, PS15-1502 has a disparate impact on prevention funding in 
those Deep South States, creating a funding shortfall that is not sufficiently 
counterbalanced by increased prevention funding to state health departments. 
 
 
 
 
 
                                                 
1
 Centers for Disease Control & Prevention, FOA PS12-1201. 
2 Susan Reif, Brian Wells Pence, Irene Hall, Xiaohong Hu, Kathryn Wetten & Elena Wilson, HIV Diagnoses, 
Prevalence and Outcomes in Nine Southern States, 39(6) J. COMM. HEALTH (Dec. 2014). 
3 Centers for Disease Control & Prevention, FOA PS15-1502, at 39. 
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The Southeastern United States has the highest HIV diagnosis rate of any US region.5 
In 2011, nearly half (49%) of national HIV diagnoses reported were located in the Southern 
United States,6 which accounted for only 37% of the total US population.  
                                                 
4
 Based on eligible MSAs in FOA PS15-1502; data taken from 2012 CDC Surveillance Report. 
5 Susan Reif, Donna Safley, Elena Wilson & Kathryn Whetten, HIV/AIDS in the Southern US: Trends from 2008-
2011 Show a Consistent Disproportionate Epidemic, Apr. 2014, available at 
http://southernaidsstrategy.org/research. 
6 The US Census Bureau defines the South as including Alabama, Arkansas, Delaware, District of Columbia, 
Florida, Georgia, Kentucky, Louisiana, Maryland, Mississippi, Oklahoma, North Carolina, South Carolina, 
Tennessee, Texas, Virginia, West Virginia. 
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SASI’s research has focused on a subgroup of Southern states7 that are 
disproportionately affected by HIV and that share certain characteristics such as overall 
poor health, high poverty rates, and negative health outcomes for those who are HIV 
positive. In the nine Deep South States, the HIV diagnosis disparity is even more 
pronounced—although they account for only 28% of the total US population, nearly 40% of 
national HIV diagnoses were located in the Deep South States.8 
SASI’s research team collaborated recently with CDC researchers to publish new 
findings about the HIV burden and outcomes in these nine Deep South States, including 
death rates and 5-year survival among persons living with HIV and AIDS in the targeted 
states region.9 Researchers found that HIV positive people in the Deep South States are 
dying at higher rates than in any other region of the country.  Twenty-seven percent of 
persons diagnosed with AIDS in the 9-state region had died within 5 years of diagnosis. 
Although survival proportions varied among Deep South States, none had a 5-year AIDS 
survival proportion “at or above the overall US survival proportion.” In Louisiana, one-third 
of persons diagnosed with AIDS and 19% of those diagnosed with HIV had died within 5 
years.   
The death rate among persons living with HIV was higher in the Deep South States 
than in any other US region, even after adjusting for age, sex, transmission category, and 
area population size.  Living outside a large urban area at diagnosis significantly predicted 
greater death rates among persons living with HIV in the 9-state region, suggesting “. . . a 
disconnect between diagnosis and maintenance of HIV care in this region . . .”10 
The National HIV/AIDS Strategy (NHAS) recognizes that the South is 
disproportionately affected by HIV.11  Ensuring that prevention resources are directed 
towards regions like the Deep South that are impacted by a high HIV burden will play a 
                                                 
7
 Alabama, Florida, Georgia, Louisiana, Mississippi, North Carolina, South Carolina, Tennessee, and Texas. 
8 Susan Reif, Donna Safley, Elena Wilson, Kathryn Whetten, HIV/AIDS in the Southern US: Trends from 2008-
2011 Show a Consistent Disproportionate Epidemic, http://southernaidsstrategy.org/research/ (April 2014). 
9 Susan Reif, Brian Wells Pence, Irene Hall, Xiaohong Hu, Kathryn Wetten & Elena Wilson, HIV Diagnoses, 
Prevalence and Outcomes in Nine Southern States, 39(6) J. COMM. HEALTH (Dec. 2014). 
10 Susan Reif, Brian Wells Pence, Irene Hall, Xiaohong Hu, Kathryn Wetten & Elena Wilson, HIV Diagnoses, 
Prevalence and Outcomes in Nine Southern States, 39(6) J. COMM. HEALTH (Dec. 2014). 
11 THE WHITE HOUSE OFFICE OF NATIONAL AIDS POLICY, NATIONAL HIV/AIDS STRATEGY FOR THE UNITED STATES 2, 12 
(2010) [hereinafter NHAS]. 
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vital role in reducing new HIV infections in the United States.12 If we are to achieve the 
goals of the NHAS, federal policy makers must focus on the Deep South Region of the US 
including areas outside the large MSAs where the HIV diagnosis rates and death rates are 
high.  
 
 
Previous CDC direct-funding prevention opportunities for CBOs drew no explicit 
distinction between CBOs located in an MSA and CBOs outside of MSAs, instead adopting a 
more nuanced approach that considered the local distribution of the HIV epidemic 
throughout the jurisdiction. CDC PS10-1003, a 2010 funding opportunity and the 
immediate predecessor to CDC PS15-1502, focused on geographical location only to the 
extent that HIV prevention should “reflect local prevention priorities and serve persons at 
high risk for acquiring or transmitting HIV.”13 Applicants were required to describe how 
their proposed program met the needs of the jurisdiction’s comprehensive HIV prevention 
plan, and the review process also considered the geographical distribution of HIV within 
each jurisdiction.14 PS10-1003 did not impose a categorical geographic eligibility 
requirement. In contrast, the PS10-1003 FOA reflected a preference for funding applicants 
distributed in proportion to the HIV epidemic geographically.15 And importantly, PS10-
1003 balanced funding opportunities “in terms of the concentration of the available 
services by geographic area.”16 
Announced in 2014, CDC PS15-1502 represented a sea change in the way that CBOs 
receive direct funding from the CDC. In contrast with previous CDC direct prevention 
funding announcements, PS15-1502 explicitly restricted grants in the Deep South States to 
CBOs located within designated MSAs.17 Thus, CBOs that were not located within those  
                                                 
12
 NHAS at viii. 
13 Centers for Disease Control & Prevention, FOA PS10-1003, at 7. 
14 Centers for Disease Control & Prevention, FOA PS10-1003, at 78. 
15 Centers for Disease Control & Prevention, FOA PS10-1003, at 97 (emphasis added). 
16 Centers for Disease Control & Prevention, FOA PS10-1003 
17 Centers for Disease Control & Prevention, FOA PS15-1502, at 37–38. For the nine Deep South States, these 
MSAs are Atlanta-Sandy Springs (GA), Austin-Round Rock (TX), Baton Rouge (LA), Birmingham-Hoover (AL), 
Charlotte-Gastonia-Concord (NC-SC), Columbia (SC), Dallas (TX), Houston-Baytown-Sugar Land (TX), Jackson 
(MS), Jacksonville (FL) Memphis (TN-MS-AR), Miami (FL), Nashville-Davidson-Murfreesboro (TN), New 
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MSAs were categorically ineligible to apply for any direct prevention funding, without 
regard to the length of time they had been serving the target population, whether they had 
received direct prevention funding under a previous CBO funding opportunity, or the HIV 
prevalence in their jurisdiction. 
 
 
The CDC’s justification for limiting CBO eligibility for direct prevention funding to 
those CBOs located in designated MSAs was to target service areas that are 
disproportionately affected by HIV and in greatest need of HIV prevention services.18 
Indeed, the funding announcement states that eligible MSAs were selected based on 
“having the highest unadjusted number of diagnoses of HIV infection in 2011,” and 
together, they accounted for 71% of the total number of HIV infection diagnoses in 2011.19  
When the Deep South States are considered in the aggregate, the justification for a 
categorical exclusion of CBOs not located within an eligible MSA seems valid. As Table 1 
shows below, total HIV diagnoses in eligible MSAs in the Deep South States accounted for 
roughly 67% of all HIV diagnoses in the Deep South States in 2012:20 
 
 
 
 
 
 
 
 
 
                                                                                                                                                             
Orleans-Metairie-Kenner (LA), Orlando (FL), Raleigh-Cary (NC), San Antonio (TX), Tampa-St. Petersburg-
Clearwater (FL), and Virginia Beach-Norfolk-Newport News (VA-NC).  
18
 See FOA PS15-1502 at 40 (“[I]n the face of increasingly constrained resources and a concentrated, 
inequitably distributed epidemic, HIV prevention funding must be allocated to those communities and 
regions that shoulder the greatest share of the national burden.”). 
19 FOA PS15-1502 at 39 (citing CDC, Diagnoses of HIV Infection in the United States and Dependent Areas, 2011, 
HIV SURVEILLANCE REP., Feb. 2013, at tbl.15(a)). 
20 CDC, Diagnoses of HIV Infection in the United States and Dependent Areas, 2012, HIV SURVEILLANCE REP., Nov. 
2014, at tbl. 18. 
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Table 1: MSA/Non-MSA HIV Diagnoses, 2012 
 MSA* HIV 
Diagnoses 
% MSA Non-MSA HIV 
Diagnoses 
% Non-
MSA 
Total # of 
HIV 
Diagnoses 
South 
Carolina 
217** 28.52 544 71.48 761 
Alabama 219 34.22 421  65.78 640 
North 
Carolina 
606** 41.45 856 58.55 1,462 
Mississippi 225** 45.64 268 54.36 493 
Louisiana 768 62.14 468 37.86 1,236 
Georgia 2,580 64.01 1,451  35.99 4,031 
Tennessee 662** 71.41 265 28.59 927 
Texas 3,664 78.37 1,011 21.63 4,675 
Florida 3,988 78.48 1,094  21.52 5,082 
Total 12,929 66.97% 6,378 33.03% 19,307 
 
*Refers to diagnoses within only PS15-1502–eligible MSAs, not all MSAs as designated by OMB 
Bulletin No. 13-01. For MSAs that span more than one state, any state’s “share” of that MSA is 
calculated by determining the number of HIV diagnoses from that state’s counties which are included 
in that MSA. 
 
**Does not include HIV diagnoses in counties for which HIV diagnosis data has been suppressed. 
Thus, MSA diagnoses may be higher than shown, and non-MSA diagnoses may be lower than shown. 
However, the effects are expected to be negligible. Specific information on which counties have 
suppressed data is on file with the authors. 
 
However, when the HIV diagnosis data is broken down by state, individual variances 
weaken the robustness of the CDC’s justification as applied to certain states. In four out of 
the nine Deep South States (South Carolina, Alabama, North Carolina, and Mississippi), the 
number of new HIV diagnoses that occur outside eligible MSAs is greater than the number 
of HIV diagnoses that occur within eligible MSAs . In other words, the areas of greatest need 
for HIV prevention services in those states are precisely those areas that are also 
categorically excluded from PS15-1502 funding.21 It follows that PS15-1502’s new MSA-
eligibility requirement dramatically reduces the amount of direct federal prevention 
funding available for CBOs in those states to address new infections. 
                                                 
21 For example, the areas of greatest need for HIV prevention services are completely inverted in South 
Carolina, with roughly 71% of new diagnoses in 2012 falling outside of a PS15-1502 eligible MSA. 
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The data for HIV prevalence tell a similar story. Table 2 shows that in the Deep 
South as a whole, 67.39% of the HIV-positive population lived in an eligible MSA in 2012:22 
 
Table 2: MSA/Non-MSA HIV-Positive Population, 2012 
 MSA* HIV+ 
Population 
% MSA Non-MSA 
HIV+ 
Population 
% Non-
MSA 
Total # of 
HIV+ 
Population 
South 
Carolina 
4,358 30.17 10,088 69.83 14,446 
Alabama 3,606 31.41 7,876 68.59 11,482 
North 
Carolina 
9,488 37.05 16,119 62.95 25,607 
Mississippi 3,589 42.54 4,848 57.46 8,437 
Georgia 25,314 66.83 12,564 33.17 37,878 
Louisiana 12,075 68.04 5,671  31.96 17,746 
Tennessee 11,425 72.52 4,329 27.48 15,754 
Texas 53,613 78.69 14,515 21.31 68,128 
Florida 75,106 78.90 20,081 21.10 95,187 
Total 198,574 67.39% 96,091 32.61% 294,665 
 
*Refers to the number of individuals living with diagnosed HIV within only PS15-1502–eligible MSAs, 
not all MSAs as designated by OMB Bulletin No. 13-01. For MSAs that span more than one state, any 
state’s “share” of that MSA is calculated by determining the number of HIV-positive individuals living 
in that state’s counties which are included in that MSA. 
 
When considered state-by-state, however, the distribution of those living with HIV 
closely tracks the distribution of new HIV diagnoses in the states. In the same four Deep 
South States (South Carolina, Alabama, North Carolina, and Mississippi), the percentage of 
HIV-positive individuals who do not live in a PS15-1502–eligible MSA is substantially 
greater than in the other five Deep South States. Furthermore, the percentage of HIV-
positive individuals who do not live in an eligible MSA in those four states is significantly 
greater than the percentage of HIV-positive individuals who do live in an eligible MSA—in 
all four states, more than 50% of HIV-positive individuals live outside an eligible MSA.23 
The implication is that at least in those states, a significant proportion of HIV-positive 
individuals and those at risk for HIV are receiving diminished prevention services—if any 
                                                 
22
 CDC, Diagnoses of HIV Infection in the United States and Dependent Areas, 2012, HIV SURVEILLANCE REP., 
Nov. 2014, at tbl. 20. 
23
 See also Appendix A. 
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services at all—because the CBOs that are providing those services are precluded from 
applying for direct CDC prevention funding. 
 The stakes are high—in 2010, 132 CBOs nationwide received $41,845,830 in direct 
prevention funding through PS10-1003.24 And the stakes are especially high for the Deep 
South States, with 40 CBOs in the Deep South receiving $13,121,195 in 2010—nearly one-
third of the total PS10-1003 funding.25 These numbers are similar to what Deep South 
CBOs received in 2004. Under CDC PA-04064, the direct prevention funding opportunity 
immediately preceding PS10-1003, 43 Deep South CBOs received a total of $15,040,004.26 
Appendices B and C display a list of all Deep South CBOs that received funding under PA-
04064 and PS10-1003, the amount of direct prevention funding that each CBO received, 
and whether that CBO would have been eligible to apply for direct prevention funding 
under PS15-1502.  
As Appendix B shows, over a quarter of the 43 CBOs that received funding in 2004 
were categorically excluded from applying for prevention funds under PS15-1502 solely by 
virtue of their non-eligible-MSA status. Had the MSA-eligibility requirement applied in 
2004, those 12 CBOs would have lost out on a combined $3,838,975, or an average of 
$319,914 per organization. Nor is the impact of PS15-1502 limited to only a few states. 
Rather, the MSA-eligibility requirement, if applied in 2004, would have excluded CBOs in 
eight of the nine Deep South States (Florida, Alabama, South Carolina, Georgia, Mississippi, 
Texas, Louisiana, and North Carolina) from crucial prevention funds.  
Although the effects of the PS15-1502 MSA-eligibility requirement are somewhat 
diminished when applied to CBOs that applied under PS10-1003, Appendix C shows that 
PS15-1502 would still have had substantial and appreciable effects on the Deep South 
States in 2010. Had the MSA-eligibility requirement been applied to PS10-1003, 8 out of 40 
                                                 
24
 CDC, Awards by State: FY 2010, available at http://www.cdc.gov/hiv/pdf/policies_funding_ 
awards2010.pdf. 
25 See Appendix C. 
26 See Appendix B. PA-04064 grantee information was calculated by the following method: (1) according to 
the CDC PA-04064 Quick Facts, awards were announced to the public in May of 2004; (2) all awards in 2004 
in all 50 states for CFDC number 93939 (HIV Prevention Activities, Non-Governmental Organization Based) in 
the U.S. Tracking Accountability in Government Grants System (TAGGS) were searched; (3) only awards titled 
“HIV Prevention Projects for CBOs” were considered; and (4) only those recipients which were located in a 
ZIP code corresponding to one of the Deep South States, and their corresponding grant award under PA-
04064, were added to the table. 
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CBOs would have been barred from applying for funding and would have lost a combined 
$2,570,302, or an average of $321,287 per organization. Furthermore, the MSA-eligibility 
requirement would have excluded funded CBOs in over half of the Deep South States 
(Georgia, Alabama, Texas, Florida, and Mississippi).  
In summary, the HIV diagnosis and prevalence data show that although the PS15-
1502’s MSA-eligibility requirement is facially neutral, it has the net effect of funneling 
significant amounts of prevention funding away from the Deep South States, which already 
bear a disproportionate HIV burden as a region. The MSA-eligibility requirement reduces 
essential prevention funding in states where HIV is not concentrated in metropolitan 
centers.  
 
 
As we’ve demonstrated above, the PS15-1502 eligibility restrictions create a 
significant prevention funding shortfall in several Deep South States. Because the disease 
burden in several Deep South States is located outside eligible MSAs, many CBOs that had 
previously received direct prevention funding are currently barred from applying for 
funding under PS15-1502. Although those CBOs also have received CDC funding indirectly 
through their state health departments, this funding does not make up for the shortfall 
created by PS15-1502.  
CDC PS12-1201 is the most recent CDC prevention funding opportunity for health 
departments in all fifty states, the District of Columbia, U.S. territories, and local health 
departments that serve ten designated MSAs or Metropolitan Divisions.27 As would be 
expected, the CDC directs that for core funding for HIV prevention programs (Category A 
funding), each health department consider the jurisdiction’s distribution of HIV in its 
funding decisions.28 Health departments are also required to identify each city or MSA with 
at least 30% of the epidemic in the jurisdiction and report to the CDC the amount of 
                                                 
27 These ten MSAs and MDs are Atlanta, Baltimore, Chicago, Fort Lauderdale, Houston, Los Angeles, Miami, 
New York City, Philadelphia, and San Francisco. The MSAs located in the Deep South States are: Atlanta, Fort 
Lauderdale, Houston, and Miami. 
28 See Centers for Disease Control & Prevention, FOA PS12-1201, at 12 (“Applicants are expected to allocate 
programmatic and financial resources to local areas based on the burden of disease.”). 
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funding allocated to those areas and how the funding was used.29 Although in most states, 
CBOs outside of eligible MSAs do receive some CDC prevention funding through their state 
health departments, the health departments are not awarded additional dollars to 
supplement the shortfall to those CBOs created by PS15-1502.   
PS12-1201 Category B funds, designed for disproportionately affected populations, 
are directed to testing programs, at least 70% of which must be in healthcare settings. Only 
30% of Category B funding can be used for non-healthcare settings (CBOs or other service 
organizations). As with Category A funds, state health departments are not awarded 
additional funds under Category B to supplement the shortfall created by PS15-1502. 
Furthermore, an informal survey of state health departments in the nine Deep South 
States conducted by SASI reveals that most state health departments distribute their CDC 
prevention funds based on the geographic breakdown of the epidemic in their states. 
However, the proportion of funds allocated to CBOs and local health departments appears 
to vary by state. What is apparent from the survey is that the funding received by CBOs 
from state health departments does not cover the loss of direct funding that could have 
been received were it not for PS15-1502’s MSA-eligibility requirement.30 
 
SASI supports the goals of the CDC’s High Impact Prevention policy.  We support 
geographic targeting of resources, which generally means targeting heavily impacted urban 
jurisdictions.  As is clear from the foregoing analysis, however, much of the Deep South HIV 
epidemic is concentrated outside of MSAs eligible for direct CBO prevention funding.  The 
Deep South region is already experiencing high rates of new HIV diagnoses, high death 
rates and low survival rates.  Recent SASI/CDC research also found that living outside a 
large urban area at the time of diagnosis significantly predicted greater death rates among 
                                                 
29 FOA PS12-1201, at 21. 
30 Relying on state health departments to fill services that would have been provided by CBOs were they able 
to receive PS15-1502 funding is unsatisfactory because state health departments are not fungible with CBOs. 
For instance, they serve different purposes, have different stakeholders, and have different relationships with 
the target communities they are serving. 
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persons living with HIV in the Deep South region.31 Reduced prevention funding for CBOs 
in the Deep South, groups that are uniquely positioned to reach communities at risk for 
HIV, will only serve to increase the HIV burden in this region. Taking funding away from a 
region where a substantial proportion of the individuals diagnosed with HIV reside will 
very likely result in continued growth in HIV infections. 
 
 
SASI calls on the CDC to allocate HIV prevention resources to address the HIV epidemic 
in suburban and rural regions where HIV diagnosis and death rates are high and survival 
rates after an HIV or AIDS diagnosis are low. 
SASI calls on the CDC to provide targeted HIV prevention efforts in rural and suburban 
areas that are informed by the epidemic profile of each state and tailored geographically by 
the social and cultural context in each state.  
SASI calls on the CDC to create an immediate funding mechanism for CBOs in the Deep 
South Region that targets the HIV epidemic outside the MSAs eligible for funding under 
PS15-1502. This funding should be used by CBOs in those states to develop models and 
demonstration projects for addressing HIV prevention outside large urban jurisdictions. In 
the long-term, SASI calls on the CDC to broaden the eligibility for CBO prevention funding 
in future HIV prevention funding announcements.   
 
We look forward to discussing our findings with the CDC and to moving forward 
with solutions. 
 
                                                 
31
 Susan Reif, Brian Wells Pence, Irene Hall, Xiaohong Hu, Kathryn Wetten & Elena Wilson, HIV Diagnoses, 
Prevalence and Outcomes in Nine Southern States, 39(6) J. COMM. HEALTH (Dec. 2014). 
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PA-04064 Grantee Funding Award PS15-1502 
Eligible? 
AID Atlanta (Atlanta, GA) 397,423 Yes 
AIDS Education and Services for Minorities, 
Inc. (Atlanta, GA) 
438.455 Yes 
AIDS in Minorities, Jefferson County 
(Birmingham, AL) 
285,578 Yes 
AIDS Service Association of Pinellas (Pinellas, 
FL) 
413,710 Yes 
AIDS Services of Austin (Austin, TX) 362,584 Yes 
AIDS Survival Project (Atlanta, GA) 319.483 Yes 
Beat-AIDS, Inc. (San Antonio, TX) 435,274 Yes 
Basic NWFL, Inc. (Panama City, FL) 309,872 No 
Brotherhood, Inc., formerly The Brotherhood 
(New Orleans, LA) 
397,423 Yes 
Building Bridges, Inc. (Jackson, MS) 286,862 Yes 
Camillus Health Concern, Inc. (Miami, FL) 437,791 Yes 
Change Happens! (Houston, TX) 481,754 Yes 
Community AIDS Resource, Inc. d/b/a Care 
Resource (Miami, FL) 
265,993 Yes 
Comprehensive AIDS Program of Palm Beach 
County, Inc. (West Palm Beach, FL) 
382,216 Yes 
Center for Multicultural Wellness Prevention 
(Orlando, FL) 
349,819 Yes 
Community Health Care Center One (Fort 
Lauderdale, FL) 
278,387 Yes 
Empower U (Miami, FL) 394,338 Yes 
Excelth, Inc/Health Care Network (New 
Orleans, LA) 
376,864 Yes 
Glades Health, Intl, Inc. (Belle Glade, FL) 325,550 No 
Great Expectations Foundation (New Orleans, 
LA) 
259,356 Yes 
Health Services Center, Inc. (Anniston, AL) 194,979 No 
Healthy Start Coalition of St. Lucie (Fort Pierce, 
FL) 
367,727 No 
Houston Area Community Services, Inc. 
(Houston, TX) 
447,447 Yes 
HopeHealth, Inc. (Florence, SC) 401,429 No 
Institute of Women and Ethnic Studies (New 
Orleans, LA) 
247,989 Yes 
Legacy Community Health Services, Inc. 
(Houston, TX) 
459,930 Yes 
Miracle of Love, Inc. (Orlando, FL) 393,504 Yes 
Minority AIDS Coalition of Jacksonville 385,266 Yes 
14 
 
(Jacksonville, FL) 
New Orleans/AIDS Task Force, Inc. (New 
Orleans, LA) 
389,631 Yes 
Our Common Welfare (Decatur, GA) 361,746 No 
Okaloosa AIDS Support & Informational 
Services (Fort Walton Beach, FL) 
230,353 No 
Palmetto AIDS Life Support Services 
(Columbia, SC) 
321,398 Yes 
Pine Belt Mental Health & Retardation Services 
(Hattiesburg, MS) 
264,338 No 
Planned Parenthood Center of El Paso (El Paso, 
TX) 
393,872 No 
Renaissance III, Inc. (Dallas, TX) 257,222 Yes 
Saint Joseph’s Mercy Care Foundation (Atlanta, 
GA) 
349,508 Yes 
South Carolina HIV AIDS Council (Columbia, 
SC) 
415,763 Yes 
Southwest Louisiana Area Health Education 
Center (Lafayette, LA) 
362,876 No 
South Texas Council on Alcohol and Drug 
Abuse (Laredo, TX) 
361,522 No 
Tri-County Community Health Center, Inc. 
(Newton Grove, NC) 
264,711 No 
Union Positiva, Inc. (Miami, FL) 389,278 Yes 
Village South, Inc. (Miami, FL) 269,542 Yes 
Wright House Wellness Center (Austin, TX) 311,421 Yes 
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PA-04064 Grantee Funding Award PS15-1502 
Eligible? 
AID Atlanta (Atlanta, GA) 389,580 Yes 
AID Gwinnett, Inc. (Duluth, GA) 315,836 No 
AIDS Action Coalition (Huntsville, AL) 364,830 No 
AIDS Arms Network, Inc. (Dallas, TX) 315,836 Yes 
AIDS Foundation Houston, Inc. (Houston, TX) 315,836 Yes 
AIDS Services of Austin (Austin, TX) 337,248 Yes 
Aletheia House, Inc. (Birmingham, AL) 307,612 Yes 
Beat-AIDS, Inc. (San Antonio, TX) 389,580 Yes 
Brotherhood, Inc., formerly The Brotherhood 
(New Orleans, LA) 
389,580 Yes 
Broward House, Inc. (Broward, FL) 240,050 Yes 
Building Bridges, Inc. (Jackson, MS) 389,580 Yes 
Care Resource (Charlotte, NC) 389,580 Yes 
Change Happens! (Houston, TX) 337,248 Yes 
Comprehensive AIDS Program of Palm Beach 
County, Inc. (West Palm Beach, FL) 
337,248 Yes 
The Coastal Bend AIDS Foundation (Corpus 
Christi, TX) 
364,830 No 
Dallas County Hospital District (Dallas, TX) 364,830 Yes 
Empower U (Miami, FL) 406,967 Yes 
Gay Lesbian Community Center of Greater Ft. 
Lauderdale (Wilton Manors, FL) 
315,836 No 
HIV/AIDS Alliance for Region Two, Inc. (Baton 
Rouge, LA) 
240,050 Yes 
Hope and Health Center of Central Florida 
(Winter Park, FL) 
315,836 No 
Houston Area Community Services, Inc. 
(Houston, TX) 
256,300 Yes 
Institute of Women and Ethnic Studies (New 
Orleans, LA) 
256,300 Yes 
Jacksonville Area Sexual Minority Youth 
Network (Jacksonville, FL) 
240,050 Yes 
Latinos Salud, Inc. (Wilton Manors, FL) 240,050 No 
Legacy Community Health Services, Inc. 
(Houston, TX) 
337,248 Yes 
Miracle of Love, Inc. (Orlando, FL) 337,248 Yes 
My Brother’s Keeper, Inc. (Ridgeland, MS) 315,836 No 
New Orleans/AIDS Task Force, Inc. (New 
Orleans, LA) 
389,580 Yes 
Palmetto AIDS Life Support Services 
(Columbia, SC) 
389,580 Yes 
Positive Impact, Inc. (Atlanta, GA) 389,580 Yes 
16 
 
Quality Home Care Services, Inc. (Charlotte, 
NC) 
364,830 Yes 
Regional HIV/AIDS Consortium (Charlotte, NC) 240,050 Yes 
River Region Human Services, Inc. 
(Jacksonville, FL) 
315,836 Yes 
Saint Joseph’s Mercy Care Foundation (Atlanta, 
GA) 
337,248 Yes 
South Carolina African American HIV/AIDS 
Council (Columbia, SC) 
337,248 Yes 
South Texas Council on Alcohol and Drug 
Abuse (Laredo, TX) 
337,248 No 
St. Hope Foundation (Houston, TX) 315,836 Yes 
Urban League of Greater Dallas (Dallas, TX) 240,050 Yes 
Women On Maintaining Education and 
Nutrition (Nashville, TN) 
315,836 Yes 
Wright House Wellness Center (Austin, TX) 337,248 Yes 
 
 
